Macrogenics (MGNX)

$30.07 1.09 (3.50%)
17:54 EDT MGNX Stock Quote Delayed 30 Minutes

Why MacroGenics Stock Is Soaring Today

MacroGenics Inc (MGNX) is surging today after solid Phase-III trial results on its later-stage breast cancer treatment. Should you buy MGNX stock?

athenahealth, Inc (ATHN), Yelp Inc (YELP) Leads Today’s Top 30 Investor Filings

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 1.27B
PE Ratio -37.59
EPS -0.8
Volume (Avg. Vol.) 1.27M
Day's Range 29.90 - 31.47
52-Week Range 5.00 - 33.61
Dividend & Yield N/A (N/A)